Skip to main content

Table 3 BMI and Hematological profiles of VL patients at baseline and end of treatment with and without iron and folic acid supplementation at UoG-LRTC and MSF-KTC northwest Ethiopia, 2017

From: Effect of iron-folic acid supplementation on change of hemoglobin among visceral Leishmaniasis patients in northwest Ethiopia: a retrospective follow up study

Characteristics

Treatment facilities

MSF-KTC (n = 303)

 

UoG-LRTC (n = 299)

Initial

Final

P-value

Initial

Final

P-value

Mean (±SD)

Mean (±SD)

 

Mean (±SD)

Mean (±SD)

 

WBC (×103/μl)

1.98 (1.4)

3.4 (1.5)

< 0.001

2.3 (1.3)

3.8 (1.4)

< 0.001

Hemoglobin

8.4 (4.7)

9.2 (1.7)

0.002

9.0 (4.8)

10.39 (1.8)

< 0.001

Mean cell volume (MCV)

79.2 (7.3)

81.0 (9.0)

< 0.001

82.0 (9.3)

85.5 (8.6)

< 0.001

BMI

17.4 (1.6)

17.9 (1.8)

< 0.001

16.5 (1.6)

16.9 (1.6)

< 0.001

  1. WBC white blood cell, IQR Interquartile range, SD standard deviation, MCV mean cell Volume, BMI Body Mass Index
Back to article page

BMC Hematology

ISSN: 2052-1839

Contact us